
Salvatore Scali
Professor of Surgery and Program Director for the Vascular Surgery Fellowship at the University of Florida, specializing in aortic disease and advanced endovascular therapies.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Aug 2, 2026
Landmark Paper Series: Abdominal Aortic Aneurysm
20:56
21:05
21:12
21:25

Anders WanhainenGUEST
So obviously we need to always re-evaluate every 10th or 15th years our practice.

Salvatore ScaliGUEST
I get conflicted with this one because obviously the value proposition was that you were supposed to prevent the patient from dying from their aneurysm.

Salvatore ScaliGUEST
And certainly the early safety signal of EVAR, even in the early era of endographs with a 0.3 to 0.6 30-day mortality rate, that is exactly what it is nowadays.

Salvatore ScaliGUEST
We see an elective EVAR mortality rate on average at a population level of usually less than 1%.
18 MINS LATER
D
39:58David StoneGUEST
So I think that those lower rupture potentials and the repeated documentation of safe surveillance, particularly for smaller aneurysms, should be reassuring for everyone.